Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy
Authors:
- 1 July 2008
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 57 (1) , 16-32
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Metabolic Syndrome and Subclinical Atherosclerosis in Patients Infected with HIVClinical Infectious Diseases, 2007
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Recent National Cholesterol Education Program Adult Treatment Panel III Update: Adjustments and OptionsThe American Journal of Cardiology, 2005
- HIV infection, HAART, and endothelial adhesion molecules: current perspectivesThe Lancet Infectious Diseases, 2004
- Prevalence of Hypertension in HIV-Positive Patients on Highly Active Retroviral Therapy (HAART) Compared with HAART-Na ve and HIV-Negative Controls: Results from a Norwegian Study of 721 PatientsEuropean Journal of Clinical Microbiology & Infectious Diseases, 2003
- Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS, 2003
- HIV Protease Inhibitor Induces Fatty Acid and Sterol Biosynthesis in Liver and Adipose Tissues Due to the Accumulation of Activated Sterol Regulatory Element-binding Proteins in the NucleusJournal of Biological Chemistry, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Circulating cell adhesion molecules in HIV1-infected patients as indicator markers for AIDS progressionResearch in Immunology, 1997
- Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patientsAnnals of Neurology, 1983